Manuscripts
Showing 1591 manuscripts.
Evaluation of Recombinant Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccines RSV/delta NS2/delta 1313/I1314L and RSV/276 in RSV-Seronegative Children
Citation
Coleen K. Cunningham, Ruth A. Karron, Petronella Muresan, Matthew S. Kelly, Elizabeth J. McFarland, Charlotte Perlowski, Jennifer Libous, Jennifer Oliva, Patrick Jean-Philippe, Jack Moye Jr., Elizabeth Schappell, Emily Barr, Vivian Rexroad, Benjamin Johnston, Ellen G. Chadwick, Mikhaela Cielo, Mary Paul, Jaime G. Deville, Mariam Aziz, Lijuan Yang, Cindy Luongo, Peter L. Collins, Ursula J. Buchholz, IMPAACT 2018 Study Team. Evaluation of Recombinant Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccines RSV/delta NS2/delta 1313/I1314L and RSV/276 in RSV-Seronegative Children. Journal of Infectious Diseases. 2022 Dec 13; 226(12):2069-2078. PMID: 35732186.Year
2022
Journal
Journal of Infectious Diseases
Study
IMPAACT 2018
Pharmacokinetics and Safety of Three Months of Weekly Rifapentine and Isoniazid for Tuberculosis Prevention in Pregnant Women
Citation
Jyoti S Mathad, Rada Savic, Paula Britto, Priya Jayachandran, Lubbe Wiesner, Grace Montepiedra, Jennifer Norman, Nan Zhang, Ellen Townley, Nahida Chakhtoura, Sarah Bradford, Sandesh Patil, Stephanie Popson, Tsungai Chipato, Vanessa Rouzier, Deborah Langat, Amphan Chalermchockcharoentkit, Portia Kamthunzi, Amita Gupta, Kelly E Dooley, IMPAACT 2001 Study Team. Pharmacokinetics and Safety of Three Months of Weekly Rifapentine and Isoniazid for Tuberculosis Prevention in Pregnant Women. Clinical Infectious Diseases. 2022 May 03; 74(9):1604-1613. PMID: 34323955.Year
2022
Journal
Clinical Infectious Diseases
Study
IMPAACT 2001
Abacavir dosing in neonates from birth to 3 months of life: a population pharmacokinetic modelling and simulation study
Citation
Adrie Bekker, Edmund V. Capparelli, Avy Violari, Mark F. Cotton, Mae Cababasay, Jiajia Wang, Ruth Mathiba, Lubbe Wiesner, Andrew Wiznia, Pearl Samson, Renee Browning, Jack Moye, Firdose L. Nakwa, Bobbie Graham, Eric Decloedt, Helena Rabie, Mark Mirochnick, Tim R. Cressey, IMPAACT P1106 team. Abacavir dosing in neonates from birth to 3 months of life: a population pharmacokinetic modelling and simulation study. Lancet HIV. 2022 Jan 05; 9(1):e24-e31. PMID: 34883066; PMCID: PMC8760861.Year
2022
Journal
Lancet HIV
Study
P1106
Influence of NAT2 genotype and maturation on isoniazid exposure in low-birth-weight and preterm infants with or without HIV exposure
Citation
Agathe Béranger, Adrie Bekker, Belén P. Solans, Mark F. Cotton, Mark Mirochnick, Avy Violari, Jiajia Wang, Mae Cababasay, Lubbe Wiesner, Renee Browning, Jack Moye, Edmund V. Capparelli, Radojka M. Savic. Influence of NAT2 genotype and maturation on isoniazid exposure in low-birth-weight and preterm infants with or without HIV exposure. Clinical Infectious Diseases. 2022 Sep 29; PMID: 35134861; PMCID: PMC9522418.Year
2022
Journal
Clinical Infectious Diseases
Study
P1106
Assessment of minority frequency pretreatment HIV drug-resistant variants in pregnant women and associations with virologic non-suppression at term
Citation
Ceejay L. Boyce, Ingrid A. Beck, Sheila M. Styrchak, Samantha R. Hardy, Jackson J. Wallner, Ross S. Milne, R. Leavitt Morrison, David Shapiro, Esaú C João, Mark Mirochnick, Lisa M. Frenkel. Assessment of minority frequency pretreatment HIV drug-resistant variants in pregnant women and associations with virologic non-suppression at term. PLoS One. 2022 Sep 27; 17(9):e0275254. PMID: 36166463; PMCID: PMC9514603.Year
2022
Journal
PLoS One
Study
P1081
Effects of Initiating Raltegravir-Based Versus Efavirenz-Based Antiretroviral Regimens During Pregnancy on Weight Changes and Perinatal Outcomes: NICHD P1081
Citation
Conrado Milani Coutinho, Meredith G. Warshaw, Geraldo Duarte, Alice Stek, Avy Violari, Cristina B. Hofer, Jaime G. Deville, James Samwel Ngocho, José Henrique Pilotto, Mario Dias Correa Jr., David E. Shapiro, Trevon L. Fuller, Nahida Chakhtoura, Mark Mirochnick, Esaú C. João. Effects of Initiating Raltegravir-Based Versus Efavirenz-Based Antiretroviral Regimens During Pregnancy on Weight Changes and Perinatal Outcomes: NICHD P1081. Journal of Acquired Immune Deficiency Syndromes. 2022 Dec 01; 91(4):403-409. PMID: 36049477; PMCID: PMC9613542.Year
2022
Journal
Journal of Acquired Immune Deficiency Syndromes
Exploring the value of Mycobacterium tuberculosis modified lipoprotein as a potential biomarker for TB detection in children
Citation
Xinxin Yang, Matthew F Wipperman, Sharon Nachman, Nicole S Sampson. Exploring the value of Mycobacterium tuberculosis modified lipoprotein as a potential biomarker for TB detection in children. BMC Infectious Diseases. 2022 Feb 17; 22(1):158. PMID: 35177035; PMCID: PMC8851740.Year
2022
Journal
BMC Infectious Diseases
Study
P1041
Accelerating investigation of new HIV drugs in pregnancy: advancing the research agenda from theory to action
Citation
Martina Penazzato, Shahin Lockman, Angela Colbers, Françoise Renaud, Alexandra Calmy, Polly Clayden, Marissa Vicari, Imelda C Mahaka, Jennifer M Zech, Cadi Irvine, Elaine J Abrams, Participants of the WHO-IMPAACT Workshop “Approaches to Enhance and Accelerate Study of New Drugs for HIV and Associated Infections in Pregnant Women”. Accelerating investigation of new HIV drugs in pregnancy: advancing the research agenda from theory to action. Journal of the International AIDS Society. 2022 Jul 01; 25(Suppl 2):e25912. PMID: 35851834; PMCID: PMC9294865.Year
2022
Journal
Journal of the International AIDS Society
Caregiver willingness to give TPT to children living with drug-resistant TB patients
Citation
V Rouzier, M Murrill, S Kim, L Naini, J Shenje, E Mitchell, M Raesi, M Lourens, A Mendoza, F Conradie, N Suryavanshi, M Hughes, S Shah, G Churchyard, S Swindells, A Hesseling, A Gupta. Caregiver willingness to give TPT to children living with drug-resistant TB patients. International Journal of Tuberculosis and Lung Disease. 2022 Oct 01; 26(10):949-955. PMID: 36163664; PMCID: PMC9524515.Year
2022
Journal
International Journal of Tuberculosis and Lung Disease
Study
IMPAACT 2003/ACTG 5300
Hepatotoxicity and Liver-Related Mortality in Women of Childbearing Potential Living With Human Immunodeficiency Virus and High CD4 Cell Counts Initiating Efavirenz-Containing Regimens
Citation
Debika Bhattacharya, Amita Gupta, Camlin Tierney, Sharon Huang, Marion Peters, Tsungai Chipato, Frances Martinson, Neaka Mohtashemi, Dingase Dula, Kathy George, Nahida Chaktoura, Karin L Klingman, Devasena Gnanashanmugam, Judith S Currier, Mary G Fowler. Hepatotoxicity and Liver-Related Mortality in Women of Childbearing Potential Living With Human Immunodeficiency Virus and High CD4 Cell Counts Initiating Efavirenz-Containing Regimens. Clinical Infectious Diseases. 2021 Apr 26; 72(8):1342-1349. PMID: 32161944; PMCID: PMC8075031.Year
2021
Journal
Clinical Infectious Diseases
Study
1077BF, 1077FF